1. C08 Caffeine is a modifier of age at onset in Huntington's disease. (16th November 2010) Authors: Duru, C; Simonin, C; Richard, F; Hincker, P; Génin, M; Charles, P; Youssov, K; Burnouf, S; Azulay, J-P; Verny, C; Tranchant, C; Goizet, C; Defebvre, L; Sablonnière, B; Rousseau, M; Buée, L; Amouyel, P; Godefroy, O; Dürr, A; Bachoud-Lévi, A-C Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 81(2010)Supplement 1 Page Start: A18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. L03 Use and impact of neuroleptics in Huntington's disease: a prospective cohort study of the Huntington French speaking group. (16th November 2010) Authors: Dolbeau, G; Lombard, A; Youssov, K; Dürr, A; Charles, P; Verny, C; Azulay, J-P; Krystkowiak, P; Simonin, C; Tranchant, C; Goizet, C; Damier, P; Supiot, F; Broussolle, E; Démonet, J-F; Marie, R-M; Verin, M; Bachoud-Lévi, A-C; Maison, P Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 81(2010)Supplement 1 Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗